Previous Video
BioPharm America™ 2016: Denmark-based biotech Curasight making strides in cancer therapies
BioPharm America™ 2016: Denmark-based biotech Curasight making strides in cancer therapies

CSO and Co-Founder of Curasight Andreas Kjaer spoke with Informa Pharma Intelligence at BioPharm America ab...

Next Video
BioPharm America™ 2016: ContraVir conducting Phase II studies for combination therapy in HBV
BioPharm America™ 2016: ContraVir conducting Phase II studies for combination therapy in HBV

ContraVir CEO James Sapirstein talked with Informa Pharma Intelligence at BioPharm America 2016 about his c...